View in EDS

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Saved in:
Bibliographic Details
Title: CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.
Authors: Zhang S; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA., Ozer BH; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Omuro A; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA., Yuan Y; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA (Y.Y.)., Mendoza T; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Wall K; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Grajkowska E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Vera E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Reyes J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA (K.A.)., Penas-Prado M; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wu J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Burton EC; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Walbert T; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mikkelsen T; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA., Weathers SP; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., O'Brien B; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., de Groot J; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA., Puduvalli V; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DeAngelis L; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Pentsova E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kaley TJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Gavrilovic I; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Gerstner ER; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Gilbert MR; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2026 Mar 09; Vol. 8 (1), pp. vdag016. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42016022
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ozer+BH%22">Ozer BH</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Omuro+A%22">Omuro A</searchLink>; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA (Y.Y.).<br /><searchLink fieldCode="AU" term="%22Mendoza+T%22">Mendoza T</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wall+K%22">Wall K</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Grajkowska+E%22">Grajkowska E</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Vera+E%22">Vera E</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Reyes+J%22">Reyes J</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Aldape+K%22">Aldape K</searchLink>; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA (K.A.).<br /><searchLink fieldCode="AU" term="%22Penas-Prado+M%22">Penas-Prado M</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Burton+EC%22">Burton EC</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Walbert+T%22">Walbert T</searchLink>; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Mikkelsen+T%22">Mikkelsen T</searchLink>; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Weathers+SP%22">Weathers SP</searchLink>; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22O'Brien+B%22">O'Brien B</searchLink>; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22de+Groot+J%22">de Groot J</searchLink>; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Puduvalli+V%22">Puduvalli V</searchLink>; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22DeAngelis+L%22">DeAngelis L</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Pentsova+E%22">Pentsova E</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kaley+TJ%22">Kaley TJ</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Gavrilovic+I%22">Gavrilovic I</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Gerstner+ER%22">Gerstner ER</searchLink>; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+TS%22">Armstrong TS</searchLink>; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+MR%22">Gilbert MR</searchLink>; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2026 Mar 09; Vol. 8 (1), pp. vdag016. <i>Date of Electronic Publication: </i>2026 Mar 09 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42016022
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdag016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdag016
    Titles:
      – TitleFull: CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Ozer BH
      – PersonEntity:
          Name:
            NameFull: Omuro A
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: Mendoza T
      – PersonEntity:
          Name:
            NameFull: Wall K
      – PersonEntity:
          Name:
            NameFull: Grajkowska E
      – PersonEntity:
          Name:
            NameFull: Vera E
      – PersonEntity:
          Name:
            NameFull: Reyes J
      – PersonEntity:
          Name:
            NameFull: Aldape K
      – PersonEntity:
          Name:
            NameFull: Penas-Prado M
      – PersonEntity:
          Name:
            NameFull: Wu J
      – PersonEntity:
          Name:
            NameFull: Burton EC
      – PersonEntity:
          Name:
            NameFull: Walbert T
      – PersonEntity:
          Name:
            NameFull: Mikkelsen T
      – PersonEntity:
          Name:
            NameFull: Weathers SP
      – PersonEntity:
          Name:
            NameFull: O'Brien B
      – PersonEntity:
          Name:
            NameFull: de Groot J
      – PersonEntity:
          Name:
            NameFull: Puduvalli V
      – PersonEntity:
          Name:
            NameFull: DeAngelis L
      – PersonEntity:
          Name:
            NameFull: Pentsova E
      – PersonEntity:
          Name:
            NameFull: Kaley TJ
      – PersonEntity:
          Name:
            NameFull: Gavrilovic I
      – PersonEntity:
          Name:
            NameFull: Gerstner ER
      – PersonEntity:
          Name:
            NameFull: Armstrong TS
      – PersonEntity:
          Name:
            NameFull: Gilbert MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 03
              Text: 2026 Mar 09
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1